Assessment of intestinal permeability using 51CrEDTA in inflammatory bowel disease

Turkish Journal of Gastroenterology

Volumn 11, Issue 4, 2000, Pages 320-325

  Arslan, G ^a   Cindoruk, M ^a   Atasever, T ^a   Yildirim, I S ^a  

^a NONE   (Turkey)

Author keywords

51CrEDTA; Inflammatory bowel disease; Intestinal permeability

Indexed keywords

EDETATE CHROMIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HUMAN; INTESTINE MUCOSA PERMEABILITY; MALE; ULCERATIVE COLITIS; URINARY EXCRETION;

EID: 0034515344     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Intestinal permeability: An overview
2. Small bowel and colonic permeability to 51CrEDTA in patients with active inflammatory bowel disease
3. Abnormal small intestinal permeability to sugars in patients with Crohn's disease of the terminal ileum and colon
4. Intestinal permeability and screening tests for coeliac disease
5. Non-invasive assessment of small intestinal damage in Crohn's disease and ulcerative colitis
6. Intestinal permeability to 51CrEDTA in patients with ulcerative colitis
7. Intestinal permeability: Clinical correlates
8. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein
9. A simple index of Crohn's disease activity
10. Absorption of 51CrEDTA in inflammatory bowel disease
11. Urinary excretion of iohexol as a marker of disease activity in patients with inflammatory bowel disease
12. Abnormal permeability in Crohn's disease. A possible pathogenic factor
13. Intestinal permeability in patients with Crohn's disease and their first degree relatives
14. Intestinal permeability compared in pediatric and adult patients with inflammatory bowel disease
15. Intestinal permeability to 99mTc-Diethylenetriaminopentaacetic acid in inflammatory bowel disease
16. Rectal electrolyte transport and mucosal permeability in ulcerative colitis and Crohn's disease
17. Mechanism of increased intestinal 51CrEDTA absorption during experimental colitis in the rat
18. Mucosal injury and inflammation in a model chronic granulomatous colitis in rats
19. Absorption of 51CrEDTA in ulcerative colitis following rectal instillation
20. Colonic permeability to 51CrEDTA in inflammatory bowel disease
21. Relationship between intestinal permeability and calprotectin concentration in gut lavage fluid
22. Increased colonic permeability in patients with ulcerative colitis: An in vitro study
23. Experimental colonic inflammation and ulceration. Permeation of water-soluble contrast medium as a measure of 'disease' activity
24. Clinical implications of the sugar absorption test: Intestinal permeability test to assess mucosal barrier function
25. Relationship between intestinal permeability to 51CrEDTA and inflammatory activity in asymptomatic patients with Crohn's disease
26. Reversibility of increased intestinal permeability to 51CrEDTA in patients with gastrointestinal inflammatory disease
27. Improvement of abnormal lactulose/rhamnose permeability in active Crohn's disease of the small bowel by elemental diet
28. Intestinal epithelial barrier dysfunction in Crohn's disease
29. Pathology of regional ileitis and ulcerative colitis
30. The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease